1. Aventis Pharma S.a. (14 from 377 patents)

2. Rhone-poulenc Rorer S.a. (3 from 247 patents)

3. Centre National De La Recherche Scientifique (2 from 5,089 patents)

4. Sanofi (2 from 1,455 patents)

5. Sanofi-aventis (1 from 389 patents)

6. Rhone-poulenc S.a. (1 from 142 patents)

7. Aventis Pharma Rorer S.a. (1 from 1 patent)

1. 8980875 - Platinum-N-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof

2. 8481522 - Platinum-N-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof

3. 8309721 - HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof

4. 8163750 - Fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP 90

5. 8034939 - Isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities

6. 7674795 - Fluorene derivatives, composition containing said derivatives and the use thereof

7. 7491710 - Organophosphorus derivatives of indazoles and use thereof as medicinal products

8. 7482352 - Chemical derivatives and their application as antitelomerase agents

9. 7435820 - [object Object]

10. 7179816 - Chemical derivatives and their application as antitelomerase agents

11. 7119115 - Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology

12. 7109340 - Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use

13. 6930124 - Compounds derived from oxindoles and their therapeutic application in cancer treatment

14. 6887904 - Substituted arylcycloalkanes, compositions containing them and use thereof

15. 6887873 - Triazine derivatives and their application as antitelomerase agents